A comprehensive review of 30 years of pediatric clinical trial radiotherapy dose constraints
Pediatric Blood & Cancer · 2023-05 · 70 (5)
DOI: 10.1002/pbc.30270 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 07.03.2023. Verfasst von April Vassantachart und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, LAC+USC Medical Center, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Radiotherapy Planning, Computer-Assisted, Radiation Injuries. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background
Radiation therapy normal tissue dose constraints are critical when treating pediatric patients. However, there is limited evidence supporting proposed constraints, which has led to variations in constraints over the years. In this study, we identify these variations in dose constraints within pediatric trials both in the United States and in Europe used in the past 30 years. Procedure All pediatric trials from the Children's Oncology Group website were queried from inception until January 2022 and a sampling of European studies was included. Dose constraints were identified and built into an organ‐based interactive web application with filters to display data by organs at risk (OAR), protocol, start date, dose, volume, and fractionation scheme. Dose constraints were evaluated for consistency over time and compared between pediatric US and European trials Results One hundred five closed trials were included—93 US trials and 12 European trials. Thirty‐eight separate OAR were found with high‐dose constraint variability. Across all trials, nine organs had greater than 10 different constraints (median 16, range 11–26), including serial organs. When comparing US versus European dose tolerances, the United States constraints were higher for seven OAR, lower for one, and identical for five. No OAR had constraints change systematically over the last 30 years.
Conclusion
Review of pediatric dose‐volume constraints in clinical trials showed substantial variability for all OAR. Continued efforts focused on standardization of OAR dose constraints and risk profiles are essential to increase consistency of protocol outcomes and ultimately to reduce radiation toxicities in the pediatric population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, LAC+USC Medical Center, Los Angeles, California, USA.
- Department of Radiation Oncology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
- Radiation Oncology Program, Children's Hospital Los Angeles, Los Angeles, California, USA.
- USC/CHLA Summer Oncology, Research Fellowship, Children's Hospital Los Angeles, Los Angeles, California, USA.
- University of South Alabama College of Medicine, Mobile, Alabama, USA.
- Department of Radiation Oncology, The Gayle and Tom Benson Cancer Center, Ochsner Health System, New Orleans, Louisiana, USA.
ORCID-Profile: April Vassantachart, Kenneth Wong
Förderung
- NCI NIH HHS
Zitieren
APA
Vassantachart, A., Olch, A. J., Jones, M., Marques, C., Ronckers, C., Constine, L. S., Maduro, J. H., de Boer, C., & Wong, K. (2023). A comprehensive review of 30 years of pediatric clinical trial radiotherapy dose constraints. Pediatric Blood & Cancer, 70(5). https://doi.org/10.1002/pbc.30270
Vancouver
Vassantachart A, Olch AJ, Jones M, Marques C, Ronckers C, Constine LS, et al. A comprehensive review of 30 years of pediatric clinical trial radiotherapy dose constraints. Pediatric Blood & Cancer. 2023;70(5). doi:10.1002/pbc.30270
BibTeX
@article{Vassantachart2023,
author = {Vassantachart, April and Olch, Arthur J and Jones, Marjorie and Marques, Christophe and Ronckers, Cécile and Constine, Louis S and Maduro, John H and de Boer, Charlotte and Wong, Kenneth},
title = {A comprehensive review of 30 years of pediatric clinical trial radiotherapy dose constraints},
journal = {Pediatric Blood & Cancer},
year = {2023},
volume = {70},
number = {5},
doi = {10.1002/pbc.30270}
}
EUVIMED